High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes

PURPOSE: Brachytherapy (BT) boost after radio-chemotherapy (RCT) is a standard of care in the management of locally advanced cervical cancer (LACC). As there is no consensus on high-dose-rate (HDR) BT fractionation schemes, our aim was to report the oncological outcome and toxicity profile of four d...

Descripción completa

Detalles Bibliográficos
Autores principales: le Guyader, Maud, Lam Cham Kee, Daniel, Thamphya, Brice, Schiappa, Renaud, Gautier, Mathieu, Chand-Fouche, Marie-Eve, Hannoun-Levi, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592834/
https://www.ncbi.nlm.nih.gov/pubmed/34816022
http://dx.doi.org/10.1016/j.ctro.2021.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592834/
https://www.ncbi.nlm.nih.gov/pubmed/34816022
http://dx.doi.org/10.1016/j.ctro.2021.10.005

Ejemplares similares